Clinical significance of p16INK4A and p14ARF promoter methylation in renal cell carcinoma: a meta-analysis.
Sign Up to like & getrecommendations! Published in 2017 at "Oncotarget"
DOI: 10.18632/oncotarget.18826
Abstract: The inactivation of p16INK4A and p14ARF via promoter methylation has been investigated in various cancers. However, the clinical effects of p16INK4A and p14ARF promoter methylation on renal cell carcinoma (RCC) remain to be clarified. The… read more here.
Keywords: p14arf; methylation; promoter methylation; p16ink4a p14arf ... See more keywords